New York City based Gilgamesh Pharmaceuticals is raising $2,434,845.00 in New Equity and Debt Financing.

▤ Summary

Gilgamesh Pharmaceuticals is raising $2.43 million in new equity and debt financing. The company says the capital will support aggressive expansion and accelerate product development. Gilgamesh focuses on preclinical neuroscience and mental health drug discovery. The firm positions itself as a biotech team building innovative new chemical entities with medicinal chemistry and drug development expertise.

$ Funding

▦ Linked Companies